Cargando…
Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET/CT: SUVmax versus total lung glycolysis
BACKGROUND: (18)F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the entire lung. Since SUVmax represents the m...
Autores principales: | Schimmelpennink, Milou C., Vorselaars, Adriane D. M., Veltkamp, Marcel, Keijsers, Ruth G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565791/ https://www.ncbi.nlm.nih.gov/pubmed/31197630 http://dx.doi.org/10.1186/s13550-019-0505-x |
Ejemplares similares
-
In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?
por: Keijsers, Ruth G.M., et al.
Publicado: (2020) -
Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019) -
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects
por: Kraaijvanger, Raisa, et al.
Publicado: (2020) -
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
por: Mathijssen, H., et al.
Publicado: (2021) -
Baseline SUVmax of (18)F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma
por: Xia, Xianwu, et al.
Publicado: (2020)